Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.5 USD | -0.58% | -2.80% | +16.97% |
05-02 | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.97% | 323B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B | |
+8.08% | 167B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Daiwa Securities Starts Merck & Co. at Neutral With $70 Price Target